References
- Felmingham D. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy 2004;50(Suppl 1):3-10
- Ortho-McNeil-Janssen Pharmaceuticals I. TRUST 12, 2008. Data on file. Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2008 file number 5004-35
- Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005;11:802-7
- Karlowsky JA, Thornsberry C, Jones ME, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis 2003;36:963-70
- Lister PD. Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. Diagn Microbiol Infect Dis 2002;44:43-9
- Dunbar LM, Wunderink RG, Habib MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37:752-60
- Zithromax [package insert]. New York, NY: Pfizer Labs, 2007.
- Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 2001;29:251-6
- Levofloxacin [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceuticals, Inc., 2008.
- Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother 1999;11(Suppl 1):35-43
- Amsden GW. Pneumococcal macrolide resistance – myth or reality?. J Antimicrob Chemother 1999;44:1-6
- Cizman M, Pokorn M, Seme K, et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur J Clin Microbiol Infect Dis 1999;18:522-4
- Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997;9(Suppl 3):38-44
- Malhotra-Kumar S, Lammens C, Coenen S, et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007;369:482-90
- Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482-92
- Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 7th Edition. Wayne, PA: Clinical and Laboratory Standards Institute, 2006
- Principi N, Marchisio P, Schito GC, et al. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J 1999;18:517-23
- Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-S72
- Jonsson M, Swedberg G. Macrolide resistance can be transferred by conjugation from viridans streptococci to Streptococcus pyogenes. Int J Antimicrob Agents 2006;28:101-3
- Johnson DM, Stilwell MG, Fritsche TR, et al. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis 2006;56:69-74
- Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9
- Blondeau JM. Differential impact of macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae. Therapy 2005;2:813-18
- Whatmore AM, Efstratiou A, Pickerill AP, et al. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of ‘Atypical’ pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000;68:1374-82